Medizone/OTC: MZEI (AIDS and Hepatitis B Treatment) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medizone/OTC: MZEI (AIDS and Hepatitis B Treatment)

MZEI 0.00500

-18.0%

Oct 4 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: gtoland who wrote (773)	5/31/2000 8:25:00 PM
From: gtoland	Read Replies (1) of 783

This was from a chart they had about the R & D Milestones for the year 2000. 1. Standardize & Calibrate Medizone technologys. a. Hollow fiber technology. July thru Sept 2000 b. Prototype system production same time c. Manufacture 1000 hollow fiber disposals Aug thru Sept d. Manufacture 3 complete units same time 2. Establish an international science advisory board with monthly meeting. July and beyond. 3. Proof of concept trials (off shore) a. Dr. Hitt - Patient Selection. July thru Sept. Patient Treatment. Patient follow up. Oct and beyond. b. By foreign N.I.H. (I do not know what this is) Patient Selection. Oct thru Dec. Patient Treatment. Patient follow up. Jan 2001 and beyond. 4. Pre-clinical R&D a. Primate animal model development HCV - Negotiate R&D contract July and beyond Commence work on Animal model development SIV-1 SIV#%# testing with prototype technology Sept. b. Immunology research & clinical trial assessment Patient baseline multiplex testing. Sept Treatment and post-treatment followup multiple testing I believe there was other stuff but I could not write fast enough. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next